WEST PHARMACEUTICAL SERVICES, INC. Other Noncash Income (Expense)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Noncash Income (Expense) of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $6.00M, a 50.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$1.00M, a 134.48% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for the quarter ending 2025-12-31 was $3.00M.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$2.50M, a 219.05% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for fiscal 2025 was $7.40M, a 57.45% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for fiscal 2024 was $4.70M.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for fiscal 2023 was -$1.00M, a 150.00% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. other noncash income (expense) for fiscal 2022 was $2.00M, a 42.86% increase from fiscal 2021.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $5.00M 10-Q · filed 2026-07-23 | $8.00M derived: sum of 3 quarters · filed 2026-07-23 | $5.50M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2026-03-31 | -$1.00M 10-Q · filed 2026-04-23 | $2.00M derived: sum of 2 quarters · filed 2026-04-23 | -$500.00K derived: sum of 3 quarters · filed 2026-04-23 | $3.50M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $500.00K derived: sum of 2 quarters · filed 2026-02-17 | $4.50M derived: sum of 3 quarters · filed 2026-07-23 | $7.40M 10-K · filed 2026-02-17 | |||
| 2025-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $1.50M derived: sum of 2 quarters · filed 2026-07-23 | $4.40M 10-Q · filed 2025-10-23 | -$600.00K derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $6.90M 10-Q · filed 2026-07-23 | $1.90M derived: sum of 3 quarters · filed 2026-07-23 | $4.00M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-03-31 | $2.90M 10-Q · filed 2026-04-23 | -$2.10M derived: sum of 2 quarters · filed 2026-04-23 | $0.00 derived: sum of 3 quarters · filed 2026-04-23 | $3.90M derived: sum of 4 quarters · filed 2026-04-23 | |||
| 2024-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.90M derived: sum of 2 quarters · filed 2026-02-17 | $1.00M derived: sum of 3 quarters · filed 2026-02-17 | $4.70M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $6.00M derived: sum of 2 quarters · filed 2025-10-23 | $9.70M 10-Q · filed 2025-10-23 | -$4.80M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $7.60M 10-Q · filed 2025-07-24 | -$6.90M derived: sum of 3 quarters · filed 2026-02-17 | -$5.80M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-03-31 | $3.70M 10-Q · filed 2025-04-24 | -$10.80M derived: sum of 2 quarters · filed 2026-02-17 | -$9.70M derived: sum of 3 quarters · filed 2026-02-17 | -$3.80M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2023-12-31 | -$14.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$13.40M derived: sum of 2 quarters · filed 2026-02-17 | -$7.50M derived: sum of 3 quarters · filed 2026-02-17 | -$1.00M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $7.00M derived: sum of 2 quarters · filed 2024-10-24 | $13.50M 10-Q · filed 2024-10-24 | -$2.40M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $12.40M 10-Q · filed 2024-07-25 | -$3.50M derived: sum of 3 quarters · filed 2025-02-18 | $2.80M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-03-31 | $6.50M 10-Q · filed 2024-04-25 | -$9.40M derived: sum of 2 quarters · filed 2025-02-18 | -$3.10M derived: sum of 3 quarters · filed 2025-02-18 | $1.00M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2022-12-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$9.60M derived: sum of 2 quarters · filed 2025-02-18 | -$5.50M derived: sum of 3 quarters · filed 2025-02-18 | $2.00M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $6.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $10.40M derived: sum of 2 quarters · filed 2023-10-26 | $17.90M 10-Q · filed 2023-10-26 | $129.30M 10-Q · filed 2022-10-27 | -$169.20M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $11.60M 10-Q · filed 2023-07-27 | $11.40M 10-Q · filed 2022-07-28 | -$175.50M derived: sum of 3 quarters · filed 2024-02-20 | $2.10M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2022-03-31 | $7.50M 10-Q · filed 2023-04-27 | $7.70M 10-Q · filed 2022-04-28 | -$179.60M derived: sum of 2 quarters · filed 2024-02-20 | -$2.00M derived: sum of 3 quarters · filed 2024-02-20 | $6.10M derived: sum of 4 quarters · filed 2024-02-20 | ||
| 2021-12-31 | -$187.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$9.50M derived: sum of 2 quarters · filed 2024-02-20 | -$1.40M derived: sum of 3 quarters · filed 2024-02-20 | $1.40M 10-K · filed 2024-02-20 | |||
| 2021-09-30 | $177.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $185.70M derived: sum of 2 quarters · filed 2022-10-27 | $188.50M 10-Q · filed 2022-10-27 | ||||
| 2021-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $10.90M 10-Q · filed 2022-07-28 | $168.50M 10-Q · filed 2021-07-30 | ||||
| 2021-03-31 | $2.80M 10-Q · filed 2022-04-28 | ||||||
| 2020-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $21.10M derived: sum of 2 quarters · filed 2021-10-28 | $25.40M 10-Q · filed 2021-10-28 | $9.50M 10-Q · filed 2020-10-23 | |||
| 2020-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $27.30M 10-Q · filed 2021-07-30 | |||||
| 2020-03-31 | $4.30M 10-Q · filed 2021-04-30 | $45.60M 10-Q · filed 2020-04-24 | |||||
| 2019-09-30 | -$32.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | -$38.20M derived: sum of 2 quarters · filed 2020-10-23 | $600.00K 10-Q · filed 2020-10-23 | $16.30M 10-Q · filed 2019-10-29 | |||
| 2019-06-30 | -$6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $32.80M 10-Q · filed 2020-07-24 | |||||
| 2019-03-31 | $38.80M 10-Q · filed 2020-04-24 | ||||||
| 2018-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $3.00M derived: sum of 2 quarters · filed 2019-10-29 | $28.60M 10-Q · filed 2019-10-29 | ||||
| 2018-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $30.50M 10-Q · filed 2019-07-29 | |||||
| 2018-03-31 | $25.60M 10-Q · filed 2019-05-08 | ||||||
| 2017-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$1.60M derived: sum of 2 quarters · filed 2018-10-30 | $62.20M 10-Q · filed 2018-10-30 | ||||
| 2017-06-30 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $57.00M 10-Q · filed 2018-07-31 | |||||
| 2017-03-31 | $63.80M 10-Q · filed 2018-05-08 | ||||||
| 2016-09-30 | -$9.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$8.90M derived: sum of 2 quarters · filed 2017-10-31 | $51.10M 10-Q · filed 2017-10-31 | $3.70M 10-Q · filed 2016-10-31 | |||
| 2016-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $60.50M 10-Q · filed 2017-08-01 | -$3.30M 10-Q · filed 2016-08-01 | ||||
| 2016-03-31 | $60.00M 10-Q · filed 2017-05-05 | $1.00M 10-Q · filed 2016-05-06 | |||||
| 2015-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $1.70M derived: sum of 2 quarters · filed 2016-10-31 | $2.70M 10-Q · filed 2016-10-31 | ||||
| 2015-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $1.60M 10-Q · filed 2016-08-01 | |||||
| 2015-03-31 | $1.00M 10-Q · filed 2016-05-06 | ||||||
| 2014-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $1.90M derived: sum of 2 quarters · filed 2015-11-02 | $3.10M 10-Q · filed 2015-11-02 | ||||
| 2014-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $1.90M 10-Q · filed 2015-08-03 | |||||
| 2014-03-31 | $1.20M 10-Q · filed 2015-05-06 | ||||||
| 2013-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $2.90M derived: sum of 2 quarters · filed 2014-11-03 | $4.00M 10-Q · filed 2014-11-03 | ||||
| 2013-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $2.70M 10-Q · filed 2014-08-01 | -$7.70M 10-Q · filed 2013-08-05 | ||||
| 2013-03-31 | $1.10M 10-Q · filed 2014-05-08 | -$4.30M 10-Q · filed 2013-05-06 | |||||
| 2012-09-30 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $6.30M derived: sum of 2 quarters · filed 2013-11-04 | $4.20M 10-Q · filed 2013-11-04 | -$7.60M 10-Q · filed 2012-11-05 | |||
| 2012-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | -$4.70M 10-Q · filed 2013-08-05 | $4.70M 10-Q · filed 2012-08-06 | ||||
| 2012-03-31 | -$2.10M 10-Q · filed 2013-05-06 | $2.10M 10-Q · filed 2012-05-04 | |||||
| 2011-09-30 | -$3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$3.30M derived: sum of 2 quarters · filed 2012-11-05 | -$1.20M 10-Q · filed 2012-11-05 | -$2.20M 10-Q · filed 2011-11-07 | |||
| 2011-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $2.70M 10-Q · filed 2012-08-06 | -$3.40M 10-Q/A · filed 2011-08-08 | ||||
| 2011-03-31 | $2.10M 10-Q · filed 2012-05-04 | ||||||
| 2010-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | -$1.40M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | -$1.00M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |